baber/WOPTO huggingface dataset:
Patent NZ-330584-A (NZ)
Title: Fire resistant building sheet or membrane comprising paper impregnated with chlorinated paraffin(s) and antimony trioxide
Inventor: STACEY MARK KENNETH
IPC: D21H19/02
Filed: 1998-06-04
Abstract: A fire-resistant sheet or membrane for use as a building membrane (for example a pliable building membrane) comprising or including a paper substrate impregnated with both non-flammable chlorinated paraffin and fire retardant chemical such as antimony trioxide, the impregnation having been effected with chlorinated paraffin at an elevated temperature (100oC-200oC) at which the chlorinated paraffin is a liquid. The preferred paper substrate being craft paper, whereupon impregnation is conducted by coating, immersing or treating the paper substrate with a mixture of the chlorinated paraffin (60% to 95% wt/wt) and antimony trioxide (5% to 40% wt/wt).
Patent NZ-331866-A (NZ)
Title: Compounds for immunotherapy and immunodiagnosis of prostate cancer
Inventor: REED STEVEN G
IPC: A61K39/00
Filed: 1997-03-14
Abstract: Compounds and methods for diagnosing prostate cancer are provided. The compounds include isolated polypeptides containing at least a portion of a prostate protein. Vaccines and pharmaceutical compositions for immunotherapy of prostate cancer comprising such isolated polypeptides or DNA molecules encoding such polypeptides are also provided. The isolated polypeptides may also be used to generate antibodies useful for the diagnosis and monitoring of prostate cancer. Nucleic acid sequences for preparing probes, primers, and polypeptides are also provided.
Patent NZ-331980-A (NZ)
Title: Amphipathic peptides with alpha helices as cholesterol and other lipid uptake inhibitors
Inventor: BOFFELLI DARIO
IPC: A61P3/06
Filed: 1997-03-27
Abstract: The use of a peptide comprising one or more amphipathic regions in the preparation of a medicament for inhibiting the uptake of cholesterol or other lipids from the gut, wherein the peptide or protein having one or more amphipathic a-helices. These compounds are useful for treating or preventing hyperlipidaemia, especially hypercholesterolaemia, and/or obesity. The peptide has the following sequence: A1-B1-B2-C1-D-B3-B4-A2-C2-B5-B6-A3-C3-B7-C4-A4-B8-B9 Wherein; A1, A2, A3 and A4 independently represents aspartic acid, or glutamic acid, or homologues or analogues thereof; B1, B2, B3, B4, B5, B6, B7, B8 and B9 independently represents tryptophan, phenylalanine, alanine, leucine, tyrosine, isoleucine, valine or a-naphthylalanine, or homologues or analogues thereof; C1, C2, C3 and C4 independently represents lysine or arginine; and D represents serine, theorine, alanine, glycine or histidine, or homologues or analogues thereof.
Patent NZ-335232-A (NZ)
Title: Transgenic plants as an alternative source of lignocellulosic-degrading enzymes for degradation of cellulose
Inventor: AUSTIN-PHILLIPS SANDRA
IPC: C12N9/42
Filed: 1997-10-13
Abstract: Transgenic plants which express cellulose-degrading enzymes, methods to make the transgenic plants, and methods to use the cellulose-degrading enzymes produced by the transgenic plants are disclosed. FIG. 1 is a schematic diagram of binary vector T-DNA for an expression construct to transform plants to contain cellulase E2 of T. fusca. Promoters and structural genes are depicted as arrows which indicate the direction of transcription. Terminators are depicted as boxes. NPT II=neomycin phosphotransferase; Met-E2m=T. fusca E2 (mature form with N-terminal methionine added); MAS-ter=mannopine synthetase terminator; TML-ter=tumor morphology left terminator; MAC-pro=hybrid "MAC" promoter. FIG. 2 is a schematic diagram of binary vector T-DNA for an expression construct to transform plants to contain cellulase E3 of T. fusca. Promoters and structural genes are depicted as arrows which indicate the direction of transcription. Terminators are depicted as boxes. NPT II=neomycin phosphotransferase; Met-E3m=T. fusca E3 (mature form with N-terminal methionine added); MAS-ter=mannopine synthetase terminator; TML-ter=tumor morphology left terminator; MAC-pro=hybrid "MAC" promoter.
Patent NZ-502319-A (NZ)
Title: 3-Beta-amino and beta-azidocarboxylic acid derivates useful as endothelin receptor antagonists
Inventor: AMBERG WILHELM
IPC: A61P13/12
Filed: 1998-06-05
Abstract: An b-amino or b-azido carboxylic acid derivative has the formula (I) wherein: R1 is tetrazole or -C(=O)-R; R is OR4, -O-(CH2)p-S(O)k-R5, a 5 membered heteroaromatic system linked via a nitrogen atom, -NH-SO2-R5; A is NR7R8 or azido; W and Z are independently nitrogen or methine provided that Q is nitrogen if W and Z are methine; X is nitrogen or CR9; Y is nitrogen or CR10; Q is nitrogen or CR11 provided that if X is CR9 and Y is CR10 if Q is nitrogen; R2 and R3 are independently optionally substituted phenyl or naphthyl or phenyl or naphthyl is linked together in ortho position by a direct linkage, methylene, ethylene or ethenylene, oxygen, sulphur, SO2, NH or N-alkyl; R4 is H, alkali metal cation, alkaline earth metal cation, or a physiologically tolerated organic ammonium ion, optionally substituted cycloalkyl, alkyl or -CH2-phenyl. k is 0 to 2 and p is 1 to 4; R5 is alkyl, cycloalkyl, alkenyl, alkynyl or optionally substituted phenyl and R7 to R11 are defined in the specification. A pharmaceutical composition thereof is useful as an endothelin receptor antagonist. A compound of formula (II) A-C(R2)(R3)-CH(R1)-OH wherein A and R1 to R3 are as defined above s useful as a starting material to prepare the compounds of formula (I).
Patent NZ-502530-A (NZ)
Title: Mono-carboxylic acids (saturated or unsaturated, aliphatic or aromatic) used in preparations of corrosion inhibitor for flux-treated metal surfaces
Inventor: FROST RICHARD A
IPC: C23F11/14
Filed: 1998-07-29
Abstract: A method of inhibiting the corrosion of flux-treated metal surfaces is described.  The method comprises the step of contacting the flux-treated metal surface with a formulation of a corrosion inhibitor composition comprising one or more mono-carboxylic acids, or salts or isomers thereof, and a corrosion inhibiting surface-active agent. The mono-carboxylic acid used in the corrosion inhibitor composition is selected from the group consisting of any combination of saturated and unsaturated aliphatic and aromatic mono-carboxylic acids, and inorganic and organic salts and isomers thereof.  The corrosion inhibiting surface-active agent may be any organic or inorganic nitrate salt including water-soluble alkali or alkaline earth metal nitrate salts.  The method has been demonstrated to be an effective means of inhibiting corrosion of flux-treated metal surfaces found in the cooling systems of internal combustion engines. For this application, the aqueous medium used is an antifreeze coolant formulation comprising a liquid alcohol freezing point depressant, from about 0.1% to about 5.5% by weight of the corrosion inhibitor composition, and from about 10% to about 90% by weight water.
Patent NZ-505689-A (NZ)
Title: Transdermal delivery system for 0.5-100 mg methylphenidate having zero-order kinetics for 10-16 hours
Inventor: MANTELLE JUAN
IPC: A61K9/70
Filed: 1998-12-14
Abstract: Described is a method of treating Attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD).  Also described are compositions for topical application of methylphenidate comprising methylphenidate in a flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours
Patent NZ-506679-A (NZ)
Title: HIV inhibiting pyrimidine derivatives
Inventor: ANDRIES KOENRAAD JOZEF LODEWIJ
IPC: C07D239/50
Filed: 1999-03-24
Abstract: The use of a compound of formula (I) an N-oxide, a pharmaceutically acceptable salt or stereochemically isomeric form thereof in the manufacture of a medicament for the treatment of HIV infection, wherein: A is CH, CR4 or N, N is 0, 1, 2, 3 or 4 Q is hydrogen or -NR1R2, R1 and R2 are each independently selected from hydrogen, hydroxy, C1-12alkyl, C1-12alkoxy, C1-12alkylcarbonyl, C1-12alkyloxycarbonyl, aryl, amino, mono- or di(C1-12alkyl)amino, mono- or di(C1-12alkyl)aminocarbonyl wherein each of the aforementioned C1-12alkyl groups are optionally substituted with hydroxy, C1-6alkyloxy, hydroxyC1-6alkyloxy, carboxyl, C1 6alkyloxycarbonyl, cyano, amino, imino, aminocarbonyl, aminocarbonylamino, mono- or di(C1-6alkyl)amino, aryl and Het, or R1 and R2 taken together may form pyrrolidinyl, piperidinyl, morpholinyl, azido or mono- or di(C1-12alkyl)aminoC1-4alkyidene, R3 is hydrogen, aryl, C1-6alkylcarbonyl, C1-6alkyl, C1-6alkyoxycarbonyl, C1-6alkyl substituted with C1-6alkoxycarbonyl, R4 is independently hydroxy, halo, C1-6alkyl, C1-6alkyloxy, cyano, aminocarbonyl, nitro, amino, trihalomethyl, trihalomethyloxy or C1-6alkyl substituted with cyano or aminocarbonyl, R5 is hydrogen or C1-4 alkyl, L is C1-10alkyl, C3-10alkynyl, C3-7cycloalkyl or C1-10alkyl optionally substituted with C3 7cycloalkyl, indanyl, indolyl and phenyl, L is -X1-R6 or X2-Alk-R7, wherein R6 and R7 each independently are phenyl or substituted phenyl, X1 and X2 are each independently -NH3-, -NH-NH-, -N=N-, -O-, -S-, -S(=O)- or -S(=O)2-, Alk is C1-4alkanediyl, Aryl is phenyl or substituted phenyl, and Het is an aliphatic or aromatic heterocyclic radical.
Patent NZ-511689-A (NZ)
Title: Methods for preparing coated drug particles useful for treating respiratory disorders or pulmonary infections
Inventor: TALTON JAMES D
IPC: A61K9/00
Filed: 1999-11-18
Abstract: A  medicament  comprises a plurality  of  coated  drug particles  with  each  particle having an  average  particle size  of less than 500 mm in diameter.  The surface  of  the particles  comprises at least a first layer of biodegradable and  biocompatible polymeric coating particles.  The average thickness of the coating layer is between 1 and 500  nm  and the  coated  particles are obtained through  depositing  the polymeric  coating particles onto the surface  of  the  host drug  particle  by a process of pulsed laser ablation.   The medicament  can be used to treat a respiratory  disorder  or pulmonary infection.
Patent NZ-514706-A (NZ)
Title: Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and processes for preparing them
Inventor: HIMMELSBACH FRANK
IPC: A61K31/5355
Filed: 2000-03-14
Abstract: Described are compounds of formula (I), wherein: X is a nitrogen atom and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments that have an inhibitory effect on signal transduction mediated by tyrosine kinases, for treating diseases such as tumour diseases, and diseases of the lungs and airways.
Patent NZ-518144-A (NZ)
Title: Piperazine Compounds
Inventor: ALVARO GIUSEPPE
IPC: A61P25/22
Filed: 2000-10-05
Abstract: A compound of formula (I) where: R represents a halogen atom or a C1-4 alkyl group; R1 represents hydrogen or a C1-4 alkyl group; R2 represents hydrogen, a C1-4 alkyl, C2-6 alkenyl or a C3-7 cycloalkyl group; or R1 and R2 together with nitrogen and carbon atom to which they are attached respectively represent a 5-6 membered heterocyclic group; R3 represents a trifluoromethyl, a C1-4 alkyl, a C1-4 alkoxy, a trifluoromethoxy or a halogen group; R4 represents hydrogen, a (CH2)qR7 or a (CH2)rCO(CH2)pR7 group; R5 represents hydrogen, a C1-4 alkyl or a COR6 group; R6 represents hydrogen, hydroxy, amino,methylamino, dimethylamino, a 5 membered heteroaryl group containing 1 to 3 heteroatoms selected from oxygen, sulphur and nitrogen or a 6 membered heteroaryl group containing 1 to 3 nitrogen atoms; R7 represents hydrogen, hydroxy or NR8R9 wherein R8 and R9 represent independently hydrogen or C1-4 alkyl optionally substituted by hydroxy, or by amino; R10 represents hydrogen, a C1-4 alkyl group or R10 together with R2 represents a C3-7 cycloalkyl group; m is zero or an integer from 1 to 3; n is zero or an integer from 1 to 3; both p and r are independently zero or an integer from 1 to 4; q is an integer from 1 to 4; This is provided that when R1 and R2 together with nitrogen and carbon atom to which they are attached respectively represent a 5 to 6 membered heterocyclic group, i) m is 1 or 2; ii) when m is 1, R is not fluorine and iii) when m is 2, the two substituents R are not both fluorine. A pharmaceutical composition and a process involving formula (I) is also disclosed.
Patent NZ-518884-A (NZ)
Title: Pyrrolo[2,3-d]pyrimidine compounds
Inventor: BLUMENKOPF TODD ANDREW
IPC: C07D487/02
Filed: 2000-11-23
Abstract: A compound of formula (I) wherein R1, R2 and R3 are defined herein, are inhibitors of the enzyme protein kinases such as Janus Kinase 3 and as such are useful therapy as immunosuppressive agents for organ transplants, xeno transplantation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, Leukemia and other autoimmune diseases.
Patent NZ-519178-A (NZ)
Title: Dust and dirt separation assembly
Inventor: GREY NICHOLAS GERALD
IPC: A47L9/20
Filed: 2000-11-03
Abstract: A dust and dirt separation assembly (10) for use in  a vacuum cleaner, includes a dirty air inlet (12) and a  clean air  outlet  (13)  with  an  airflow  path  passing  firstly through  a  cyclonic  separator (11) for  separating  larger particles of dirt from the dirty air and secondly through  a filtration element (20) for separating smaller particles  of dust  from the dirty air, a dirt collection chamber (16)  to receive  dirt from the cyclonic separator and dust from  the filter  element,  and a striker mechanism (30)  including  a striker  member (31) which is operable to strike the  filter element  to  dislodge the dust from the  filter  element  so that  the dust enters the collection chamber with the larger particles  of  dirt. The striker member may be  operated  in response  to cessation of air-flow within a section  (32-35) of the air-flow path or by a mechanical actuator.
Patent NZ-521229-A (NZ)
Title: Microwave heating apparatus
Inventor: FAGRELL MAGNUS
IPC: B01J19/12
Filed: 2001-02-26
Abstract: An apparatus for heating samples such as chemical reaction mixtures, whose dielectric properties varies during the heating process using a microwave heating apparatus comprising a microwave generator (2), a waveguide (3) for guiding the generated microwaves to an applicator (4), and a deflector (26) with an inherent resonance frequency formed by a closed loop defining a plane. The resonance conditions of the resonant cavity and the coupling factor of radiation from the waveguide to the cavity are easily adjustable by a rotation of the deflector, in order to optimise the amount of absorbed power and thereby obtain control of the sample heating process.
Patent NZ-521460-A (NZ)
Title: Valve assembly with or without integrated reducer for pressurised gas container
Inventor: PISOT PHILIPPE
IPC: F17C5/06
Filed: 2001-03-23
Abstract: Disclosed is a valve assembly or an on-off pressure reducer device for a pressurized gas container designed to co-operate with a conditioning connection for filling the container. The valve assembly or on-off pressure reducer comprises a filler connection with a longitudinal axis, a guide end (18), and a thread (22) axially offset relative to said end. The end has a periphery (20) provided with at least an impression (40) protruding outside the periphery, projecting in a plane orthogonal to the longitudinal axis, the impression of the connection end being secant to a circle centered on the axis and whereof the diameter is equal to the smallest diameter of the screw thread.
Patent NZ-521681-A (NZ)
Title: Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
Inventor: HUTH ANDREAS
IPC: A61P7/02
Filed: 2001-04-24
Abstract: Substituted benzoic acid amides of formula (I) and their use as medicaments for treating diseases caused by persistent angiogenesis, and the intermediates thereof for producing these substituted benzoic acid amides are disclosed, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-523197-A (NZ)
Title: Beta-glucan that is greater than 2% soluble when mixed with water below 50 degrees celsius and forms a gel
Inventor: MORGAN KEITH RAYMOND
IPC: A23L29/206
Filed: 2001-07-03
Abstract: Beta-glucan that is cold-water soluble and capable of forming a gel is described. The solubility is greater than 2% by weight in water at a temperature below approximately 50OC. Also described is a process for preparing the â-glucan by recovering the â-glucan from an aqueous solution containing it before any gelation of the solution begins to occur. The use of the â-glucan for treating various disorders or diseases, and other uses including in foods and as an edible film is also described.
Patent NZ-523312-A (NZ)
Title: Analytical device
Inventor: MATSUSHITA HIROHISA
IPC: G01N33/552
Filed: 2000-12-19
Abstract: The present invention is an analytical device which comprises a porous piece assembly consisting of a liquid reagent-receiving porous piece (1), a labeled substance-retaining piece (2), a test piece (3) comprising a detection site (4) and a reference site (5), and a sample-absorbing porous material piece (6); and a sample-receiving porous material piece (7) disposed independently therefrom and partially communicated therewith through a connection. The analytical device of the present invention exhibits extremely high sensitivity and can accurately perform various types of analysis.
Patent NZ-525073-A (NZ)
Title: Testing an electrical device using an apparatus having magnetic switch, the state of the switch showing the state of the device
Inventor: TOMKIES ROBERT JULIAN GRETTON
IPC: G01R31/302
Filed: 2001-10-01
Abstract: An emergency lighting unit 1 that includes a test circuit activated by a magnetic switch 2 is described. To test the circuit a member 5 with a magnet 6 at the tip is used, with the magnet being brought into close proximity to the switch 2. If the lighting system is working correctly an indicator light 3 is illuminated.
Patent NZ-525348-A (NZ)
Title: Use of vegetable oil or fish oil in a process for producing fuel for diesel engine
Inventor: MURAKAMI SEISHIRO
IPC: C10L1/08
Filed: 2001-04-26
Abstract: A  process  for producing a fuel for a  diesel  engine which  comprises a first treatment step of subjecting  waste oil comprising fish oil (virgin oil or fish waste oil) or  a mixture  of  the fish oil and vegetable oil (virgin  oil  or vegetable  waste  oil) while introducing ozone  to  stirring treatment, filtering the material obtained, adding ozone  to further    pulverize    the    filtrate,    introducing    a crystallization-preventive  agent;  an   oxidation-reduction agent  and  a polymerization inhibitor are added during  the first  treatment.  Also disclosed is a treatment device  for producing said fuel.
Patent NZ-528182-A (NZ)
Title: Manual grinder for peppercorns, salt crystals and other grindable products
Inventor: ARDUINI GIOVANNI
IPC: A47J42/04
Filed: 2003-09-15
Abstract: An easy to use manual grinder for peppercorns, salt crystals and other grindable products of the type comprising a container with a shaft located therein, a grinder arrangement coupled to the shaft at a lower end thereof, a drive mechanism coupled at or near an upper end of the shaft, an externally accessible operating member coupled to the drive mechanism, said drive mechanism being contained inside a casing at an upper end of said container, said casing having an opening via which grindable products can be introduced into said container.
Patent NZ-529503-A (NZ)
Title: Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
Inventor: GICQUEL BRIGITTE
IPC: C12P21/02
Filed: 1998-08-14
Abstract: The disclosure concerns recombinant vectors replicated in mycobacteria, a set of sequences coding for exported polypeptides detected by fusion with alkaline phosphatase, in particular one polypeptide, called DP428, of about 12 kD corresponding to an exported protein found in mycobacteria belonging to the Mycobacterium tuberculosis complex. The disclosure also concerns methods and kits for detecting in vitro the presence of a mycobacterium and in particular a mycobacterium belonging to the Mycobacterium tuberculosis complex in a biological sample using said polypeptides, their fragments or polynucleotides coding for the latter. The disclosure also concerns immunogenic or vaccine compositions for preventing and/or treating infections caused by mycobacteria and in particular a mycobacterium belonging to said complex, particularly tuberculosis. (62) Divided out of 519053
Patent NZ-531998-A (NZ)
Title: A valve unit for controlling the delivery of a fuel gas
Inventor: DORIGO ROBERTO
IPC: F23N1/00
Filed: 2002-03-05
Abstract: A valve that controls the delivery of a fuel gas through a delivery duct 3 includes a valve seat 6 in the duct, a closure member 5 associated with the seat, and a motor-driven actuator 7 that acts on the closure member in order to open/close the valve seat. The valve unit also includes an electromagnetic unit 22 with a first portion 23 carrying a magnetizing winding 24 and a second portion 25 which can be fixed firmly to the first portion by magnetization. The electromagnetic unit 22 is associated with the actuator in order to act on the closure member 5 so as to close the valve seat 6, irrespective of the operative position of the actuator 7, upon the occurrence of a predetermined condition which requires the valve seat to be shut off, and the actuator means 7 is movable, together with the second portion 25 of the electromagnetic unit, during the movement to control the closure member 5 so as to open/close the valve seat, the first portion 23 of the electromagnetic unit being connected to a stationary structure of the valve unit.
Patent NZ-533645-A (NZ)
Title: Compounds for treatment of inflammation, diabetes and related disorders
Inventor: NEOGI PARTHA
IPC: C07C271/64
Filed: 2002-11-27
Abstract: Disclosed are compounds of formulae (I) and (VII), wherein the substituents are as defined in the specification. The compounds are useful in the treatment of diabetes, inflammatory and immunological disease, hyperlipidemia and coronary heart disease.
Patent NZ-534009-A (NZ)
Title: Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
Inventor: BOSCH WILLIAM H
IPC: A61K31/5377
Filed: 2002-12-09
Abstract: A nanoparticulate composition comprising the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine, or a pharmaceutically acceptable salt thereof, the compound having adsorbed on the surface thereof at least one surface stabilizer in an amount sufficient to maintain an effective average particle size of less than about 1000 nm is disclosed. This pharmaceutical composition is useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.